Koers Chalice Brands Ltd. Canadian Securities Exchange
Aandelen
CHAL
CA15756R1047
Farmaceutische producten
Omzet 2019 | 15,75 mln. 21,47 mln. 14,53 mln. | Omzet 2020 | 21,91 mln. 29,85 mln. 20,2 mln. | Marktkapitalisatie | 20,07 mln. 27,35 mln. 18,51 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2019 | -46 mln. -62,68 mln. -42,42 mln. | Nettowinst (verlies) 2020 | -10 mln. -13,63 mln. -9,22 mln. | EV/omzet 2019 | 1,28 x |
Nettoschuld 2019 | 6,22 mln. 8,48 mln. 5,74 mln. | Nettoschuld 2020 | 10,27 mln. 13,99 mln. 9,47 mln. | EV/omzet 2020 | 1,38 x |
K/w-verhouding 2019 |
-0,23
x | K/w-verhouding 2020 |
-1,89
x | Werknemers | - |
Dividendrendement 2019 * |
-
| Dividendrendement 2020 |
-
| Vrij verhandelbaar | 78,85% |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+37,29% | 6,09 mld. | |
-21,28% | 4,14 mld. | |
+4,52% | 3,23 mld. | |
-18,16% | 2,83 mld. | |
-7,70% | 2,39 mld. | |
+41,50% | 1,9 mld. | |
-4,05% | 1,57 mld. | |
-15,56% | 1,55 mld. | |
-14,62% | 1,5 mld. |